Improving global healthcare access and quality starts where the need is greatest.
Everyone deserves healthcare, but millions worldwide suffer or die because they can’t afford care or access solutions suited to their needs. Non-communicable diseases pose the greatest threat and are widespread in low- and middle-income countries, but healthcare disparities exist everywhere.
We founded TEAMFund based on the thesis that we can make significant improvements in global health using MedTech and digital health technologies. These technologies can improve healthcare access by extending clinical resources to facilitate diagnostics, monitor health, and deliver therapeutics.
Our experience reveals that emerging markets such as India and Africa are developing many promising technologies. Entrepreneurs in regions facing unmet healthcare needs are often best positioned to close these gaps. They know the constraints, systems, and infrastructure that will either support or stand in the way of success. Unfortunately, unlike established innovation centers, founders in overburdened regions lack the backing and advice needed to scale.
TEAMFund’s founders determined that to tap into the full potential of innovators targeting emerging markets, they would need a holistic approach. These entrepreneurs need financial resources, but they also need access to the networks, expertise, and mentorship enjoyed by their counterparts in developed regions. With that kind of support, these companies can grow and scale globally.
TEAMFund’s hybrid structure couples a for-profit impact investment fund with non-profit programming that informs our investments through research and provides innovators with wraparound support to anchor their success. Our portfolio of companies benefits from an 80+ worldwide team of executive-level advisors, including domain experts and CEOs from the most prominent healthcare multinationals.
Founded by industry leaders and bolstered by top-notch investment and research staff, we bring global insights and an operator mentality to impact investing.
Our board includes public health policy leaders and global innovation experts.
Director, India Program, Stanford Biodesign Adjunct Professor, Stanford School of Medicine
Dr. Adolph & Margaret Berger Professor of Medicine & Population Health, NYU Grossman School of Medicine
